As a new Core Lab under the Million Microbiomes from Humans Project, MGI empowers INRAE MetaGenoPolis in “Le microbiote français – Le French Gut”project to Propel Metagenomics Research

FHS
March 6, 2024
11:12 am

MGI, a company committed to building core tools and technology to lead life science, announced today a collaboration agreement with MetaGenoPolis, a unit within the renowned National Research Institute for Agriculture, Food and the Environment (INRAE) in France, following MetaGenoPolis’ selection as a core lab under the Million Microbiomes from Humans Project (MMHP).

Immunome buys desmoid tumor asset; UK looks into Thermo Fisher-Olink deal; Kyverna’s upsized IPO

Plus, news about Attralus, Sangamo, Mithra, NeOnc, 4D Molecular Therapeutics and Immix Biopharma: Immunome buys Ayala’s desmoid tumor asset: The biotech will pay $20 million

February 7, 2024

DEFENCE MANUFACTURING OF ACCUTOXTM CGMP FINAL DRUG PRODUCT OPTIMIZATION FOR ITS PHASE I CLINICAL TRIAL AT CITY OF HOPE – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE MANUFACTURING OF ACCUTOXTM CGMP FINAL DRUG PRODUCT OPTIMIZATION FOR ITS PHASE I CLINICAL TRIAL AT CITY

June 17, 2023

Are Surgical Outcomes Better With MDs or DOs?

For Medicare patients, surgical outcomes were similar whether they had an MD or a DO surgeon, a claims analysis suggested. After adjusting for patient factors

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.